bpc 157 human clinical trials 2026 BPC-157 — the most prescribed peptide you've never seen in a trial. 30 total subjects. Zero RCTs. A Phase 1 that was registered, enrolled, and then quietly canceled with no BPC-157 is being marketed as
Description
It is approved in over 30 countries for hepatitis B and C treatment and as an immune adjuvant
GLP-1 enhances insulin secretion when blood sugar levels are elevated and reduces glucose production by the liver
You can take the tablet on its own with just a glass of water, mix it with your food, or dissolve it to be consumed in a beverage
it's about gaining a renewed sense of vitality through increased energy levels from the vitamin injections
